US FDA approves Moderna’s mRNA flu vaccine
The US Food and Drug Administration (FDA) has approved Moderna’s mRNA-based flu vaccine for people aged 50 and older, the company said, making it the first seasonal flu vaccine using messenger RNA technology to receive FDA approval.
